Isomerase Therapeutics, NeuroVive deal

NeuroVive partnered with Isomerase to develop and commercialize preclinical cyclophilin inhibitors that NeuroVive acquired from Biotica Technology Ltd. (Cambridge, U.K.). The deal will focus on cell...